Literature DB >> 15715830

Epidemiology of depression in the Asia Pacific region.

Edmond Chiu1.   

Abstract

OBJECTIVE: To summarise studies reporting rates of depression (for the general population and older samples) and suicide in the Asia Pacific region.
METHODS: Information on local data was collected from the members of the SEBoD International Advisory Board on known epidemiological studies. Additionally, online searches were conducted using Medline and PsycInfo for the period 1994-2004.
RESULTS: Across the Asia Pacific region, rates of current or 1-month major depression ranged from 1.3% to 5.5%, rates of major depression in the previous year ranged from 1.7% to 6.7%, and lifetime rates ranged from 1.1% to 19.9%, with a median of 3.7%. Rates of suicide in the Asia Pacific region are now similar to those in Europe and the Americas. The exceptions include China and South Korea.
CONCLUSIONS: Epidemiological studies in Asian populations are rare and use various diagnostic criteria. However, studies indicate that rates of depression in Asia Pacific, whilst lower, are comparable to other western countries. As such, depression as a health issue in Asia Pacific demands greater recognition. It is important that Asian countries should have the human and financial resources to conduct large scale epidemiological surveys not only in the area of depression, but also in the broader field of mental disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15715830     DOI: 10.1080/j.1039-8562.2004.02099.x-1

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN: 1039-8562            Impact factor:   1.837


  14 in total

1.  Suicidal and depressive symptoms in Filipino home care workers in Israel.

Authors:  Liat Ayalon
Journal:  J Cross Cult Gerontol       Date:  2012-03

2.  The prevalence and predictors of severe depression among the elderly in Malaysia.

Authors:  Abdul Rashid; Ibrahim Tahir
Journal:  J Cross Cult Gerontol       Date:  2015-03

3.  [New procedures for recognition and differentiation of depression in immigrants. Case report of a patient with Turkish immigrant background].

Authors:  M Schouler-Ocak; M C Aichberger; A Heredia Montesinos; Z Bromand; M A Rapp; A Heinz
Journal:  Nervenarzt       Date:  2010-07       Impact factor: 1.214

4.  Depression and its correlates in South Africa and Ghana among people aged 50 and above: Findings from the WHO Study on global AGEing and adult health.

Authors:  Suraj Bahadur Thapa; Priscilla Martinez; Thomas Clausen
Journal:  J Psychiatry       Date:  2014-11

5.  Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders.

Authors:  Seong-Jin Cho; Jin Pyo Hong; Bong-Jin Hahm; Hong Jin Jeon; Sung Man Chang; Maeng Je Cho; Hochang B Lee
Journal:  Sleep       Date:  2009-08       Impact factor: 5.849

6.  A review on assessment and treatment for depression in malaysia.

Authors:  Firdaus Mukhtar; Tian P S Oei
Journal:  Depress Res Treat       Date:  2011-07-24

7.  12-Month naturalistic outcomes of depressive disorders in Hong Kong's primary care.

Authors:  Weng Yee Chin; Kit T Y Chan; Cindy L K Lam; Eric Y F Wan; Tai Pong Lam
Journal:  Fam Pract       Date:  2015-03-05       Impact factor: 2.267

8.  A measure of depression in a modern asian community: singapore.

Authors:  Weining C Chang; Jessie Bee Kim Koh
Journal:  Depress Res Treat       Date:  2012-10-09

9.  Shuyusan-containing serum protects SH-SY5Y cells against corticosterone-induced impairment.

Authors:  Liping Chen; Zhigao Sun; Fawei Wang; Chengyong Xu; Miao Geng; Hongyan Chen; Dongmei Duan
Journal:  Neural Regen Res       Date:  2013-08-05       Impact factor: 5.135

10.  Gender Differences in Depressive Symptom Profile: Results from Nationwide General Population Surveys in Korea.

Authors:  Ji-Hyun Kim; Maeng Je Cho; Jin Pyo Hong; Jae Nam Bae; Seong-Jin Cho; Bong-Jin Hahm; Dong-Woo Lee; Jong-Ik Park; Jun-Young Lee; Hong Jin Jeon; Sung Man Chang
Journal:  J Korean Med Sci       Date:  2015-10-16       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.